| Q2 2024 |
120 |
$1.14B |
+$181M |
-$184M |
-$2.4M |
FLR, ADMA, GMED, ADC, BCO
|
13F-HR |
8/2/2024, 09:48 AM |
| Q1 2024 |
117 |
$1.12B |
+$243M |
-$232M |
+$11.1M |
FLR, QTWO, XPO, LANC, KMPR
|
13F-HR |
5/6/2024, 02:11 PM |
| Q4 2023 |
113 |
$1.07B |
+$253M |
-$257M |
-$3.75M |
FLR, COLB, XPO, ITT, CALX
|
13F-HR |
2/7/2024, 09:42 AM |
| Q3 2023 |
118 |
$986M |
+$183M |
-$157M |
+$26.8M |
OLLI, FLR, AXS, THG, CALX
|
13F-HR |
11/1/2023, 11:57 AM |
| Q2 2023 |
114 |
$970M |
+$272M |
-$257M |
+$15.3M |
XPO, ERII, CACI, FTI, HALO
|
13F-HR |
7/31/2023, 10:12 AM |
| Q1 2023 |
144 |
$921M |
+$301M |
-$174M |
+$127M |
MODG, THC, OLLI, RDN, DOC
|
13F-HR |
5/1/2023, 09:55 AM |
| Q4 2022 |
117 |
$760M |
+$197M |
-$191M |
+$5.05M |
FTI, JBL, FLR, ALEX, KTB
|
13F-HR |
2/6/2023, 11:55 AM |
| Q3 2022 |
110 |
$690M |
$0 |
$0 |
|
RGA, DOC, PCRX, THG, OLLI
|
13F-HR |
11/8/2022, 09:29 AM |